.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
McKesson
Fish and Richardson
UBS
Daiichi Sankyo
Federal Trade Commission
Deloitte
Cerilliant
Chubb
Express Scripts

Generated: December 15, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 089718

« Back to Dashboard

NDA 089718 describes BUTALBITAL, ACETAMINOPHEN AND CAFFEINE, which is a drug marketed by Graham Dm, Hikma Pharms, Mallinckrodt, Mayne Pharma Inc, Nexgen Pharma, Nuvo Pharm Inc, Tedor Pharma Inc, Mikart, Able, Actavis Labs Ut Inc, Cnty Line Pharms, Gilbert Labs, Lannett Holdings Inc, Mallinckrodt Inc, Mirror Pharms Llc, Novast Labs Ltd, Sun Pharm Industries, Vintage Pharms, and Watson Labs, and is included in twenty-eight NDAs. It is available from fifty suppliers. Additional details are available on the BUTALBITAL, ACETAMINOPHEN AND CAFFEINE profile page.

The generic ingredient in BUTALBITAL, ACETAMINOPHEN AND CAFFEINE is acetaminophen; butalbital; caffeine. There are sixty-six drug master file entries for this compound. Fifty suppliers are listed for this compound. Additional details are available on the acetaminophen; butalbital; caffeine profile page.

Summary for 089718

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 089718

Suppliers and Packaging for NDA: 089718

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BUTALBITAL, ACETAMINOPHEN AND CAFFEINE acetaminophen; butalbital; caffeine TABLET;ORAL 089718 ANDA West-Ward Pharmaceuticals Corp 0143-1787 0143-1787-30 30 TABLET in 1 BOTTLE, PLASTIC (0143-1787-30)
BUTALBITAL, ACETAMINOPHEN AND CAFFEINE acetaminophen; butalbital; caffeine TABLET;ORAL 089718 ANDA West-Ward Pharmaceuticals Corp 0143-1787 0143-1787-05 500 TABLET in 1 BOTTLE, PLASTIC (0143-1787-05)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength325MG;50MG;40MG
Approval Date:Jun 12, 1995TE:AARLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Covington
US Army
Merck
Moodys
Harvard Business School
Baxter
UBS
Citi
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot